Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile
Journal
Clinical Microbiology and Infection
ISSN
1198-743X
Date Issued
2023
Author(s)
Mónica L. Acevedo
Aracelly Gaete-Argel
Cecilia Gonzalez
Daniela Espinoza
Pablo Pizarro
Stephan Jarpa
Ricardo Soto-Rifo
Alejandro Jara
Fernando Valiente-Echeverría
Type
Resource Types::text::journal::journal article
URL Institutional Repository
Cite this document
Acevedo, J., Acevedo, M. L., Gaete-Argel, A., Araos, R., Gonzalez, C., Espinoza, D., Rivas, S., Pizarro, P., Jarpa, S., Soto-Rifo, R., Jara, A., & Valiente-Echeverría, F. (2023). Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile. Clinical Microbiology and Infection, 29(4), 541.e1-541.e7. https://doi.org/10.1016/j.cmi.2022.11.017
Subjects
boosters
;
coronavac
;
covid-19
;
immunization programme
;
sars-cov-2
;
vaccination
;
antibodies, neutralizing
;
antibodies, viral
;
bnt162 vaccine
;
chile
;
covid-19
;
covid-19 vaccines
;
humans
;
sars-cov-2
;
vaccines
;
bnt 162b 2
;
coronavac
;
neutralizing antibody
;
placebo
;
tozinameran
;
vaxzevria
;
coronavac
;
neutralizing antibody
;
vaccine
;
virus antibody
;
adult
;
article
;
bayes theorem
;
chile
;
controlled study
;
coronavirus disease 2019
;
double blind procedure
;
female
;
follow up
;
human
;
humoral immunity
;
id50
;
information dissemination
;
male
;
markov chain monte carlo method
;
multicenter study
;
normal human
;
phase 3 clinical trial
;
preventive health service
;
public health
;
randomized controlled trial
;
severe acute respiratory syndrome coronavirus 2
;
vaccination
;
vaccine immunogenicity
;
prevention and control